As bad a reputation as artificial intelligence has gotten in the public eye as of late, it’s helping to push medicine further. Case in point, an experimental pan-coronavirus vaccine developed with AI has just passed a phase I trial in the UK. Scientists at the University of Cambridge used AI to find a kink in the armor of coronaviruses, including SARS-CoV-2, the cause of covid-19. In healthy human volunteers, the vaccine candidate appeared to be safe and generated an immune response to multiple coronaviruses. The researchers are also hoping to use their platform to develop broadly effective vaccines against flu and the Ebola virus. “We’ve overcome the problem of traditional vaccines, which have limited protection,” said study author Jonathan Heeney, a researcher from the Lab of Viral Zoonotics at Cambridge, in a statement from the university.…